We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79B
AUM Growth
+$5.52B
(+7.5%)
Cap. Flow
-$7.01B
Cap. Flow
% of AUM
-8.87%
Top 10 Holdings %
Top 10 Hldgs %
24.46%
Holding
2,559
New
284
Increased
737
Reduced
832
Closed
260
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$555M |
| 2 |
American Electric Power
AEP
|
+$272M |
| 3 |
Ulta Beauty
ULTA
|
+$161M |
| 4 |
CVS Health
CVS
|
+$160M |
| 5 |
McDonald's
MCD
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$388M |
| 2 |
Aon
AON
|
+$211M |
| 3 |
Johnson & Johnson
JNJ
|
+$209M |
| 4 |
Norfolk Southern
NSC
|
+$162M |
| 5 |
Envista
NVST
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.99% |
| 2 | Financials | 14.12% |
| 3 | Healthcare | 13.38% |
| 4 | Industrials | 11.48% |
| 5 | Consumer Discretionary | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Capri Holdings
CPRI
$1.72B
| $24K | ﹤0.01% |
485
-107
| -18% | -$5.34K |
|
1852
Comstock Resources
CRK
$3.88B
| $24K | ﹤0.01% |
2,790
-98,793
| -97% | -$1.07M |
|
1853
Green Dot
GDOT
$759M
| $24K | ﹤0.01% |
+2,428
| New | +$25.3K |
|
|
PSTX
1854
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $24K | ﹤0.01% |
7,541
-24,523
| -76% | -$63.2K |
|
|
VTRU
1855
DELISTED
Vitru Limited Common Shares
VTRU
| $24K | ﹤0.01% |
1,531
+15
| +1% | +$207 |
|
|
CCRN
1856
DELISTED
Cross Country Healthcare
CCRN
| $23K | ﹤0.01% |
1,049
+26
| +3% | +$564 |
|
1857
Lyell Immunopharma
LYEL
$348M
| $23K | ﹤0.01% |
620
+325
| +110% | +$11.7K |
|
|
OSG
1858
Octave Specialty Group
OSG
$255M
| $22K | ﹤0.01% |
1,371
-320
| -19% | -$4.45K |
|
1859
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.15B
| $22K | ﹤0.01% |
261
| – | – |
|
1860
Broadridge
BR
$18.8B
| $22K | ﹤0.01% |
107
+102
| +2,040% | +$18.8K |
|
1861
Phinia Inc
PHIN
$2.74B
| $22K | ﹤0.01% |
754
-7
| -0.9% | -$188 |
|
1862
Plumas Bancorp
PLBC
$428M
| $22K | ﹤0.01% |
+555
| New | +$20K |
|
1863
STAAR Surgical
STAA
$1.15B
| $22K | ﹤0.01% |
721
-168
| -19% | -$6.04K |
|
1864
TScan Therapeutics
TCRX
$49.9M
| $22K | ﹤0.01% |
+3,983
| New | +$18.2K |
|
1865
CryoPort
CYRX
$741M
| $21K | ﹤0.01% |
1,364
-139
| -9% | -$1.82K |
|
1866
Dine Brands
DIN
$450M
| $21K | ﹤0.01% |
432
-632
| -59% | -$30K |
|
1867
Magnite
MGNI
$3.48B
| $21K | ﹤0.01% |
2,261
-529
| -19% | -$4.18K |
|
|
RPTX
1868
DELISTED
Repare Therapeutics
RPTX
| $21K | ﹤0.01% |
3,008
-6,870
| -70% | -$38.4K |
|
1869
Aecom
ACM
$9.63B
| $20K | ﹤0.01% |
226
| – | – |
|
1870
Fortive
FTV
$18.4B
| $20K | ﹤0.01% |
368
-3,219
| -90% | -$170K |
|
1871
Manulife Financial
MFC
$74.1B
| $20K | ﹤0.01% |
921
| – | – |
|
1872
uniQure
QURE
$3.15B
| $20K | ﹤0.01% |
3,040
+110
| +4% | +$727 |
|
1873
CGI
GIB
$15.4B
| $19K | ﹤0.01% |
186
+98
| +111% | +$9.94K |
|
1874
Principal Financial Group
PFG
$24.7B
| $19K | ﹤0.01% |
246
+6
| +3% | +$435 |
|
|
SGMO
1875
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $19K | ﹤0.01% |
37,090
+2,039
| +6% | +$940 |
|
Similar funds
QCM
Lazard Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Lazard Asset Management held 2,559 positions worth $79B, up 7.5% from $73.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $7.01B in Q4 2023, closing 260 positions and reducing 832 holdings. Its most notable exit was VMware, Inc, an estimated $34.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in Dentsply Sirona worth $141M.
- Lazard Asset Management's largest Q4 2023 buy was Dentsply Sirona: 3,954,444 shares worth $141M.
- Lazard Asset Management added most to Chubb in Q4 2023, an estimated $555M increase.
- Lazard Asset Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $388M.
- Lazard Asset Management fully exited VMware, Inc in Q4 2023, selling an estimated $34.5M.
- Lazard Asset Management's ten largest holdings make up 24% of its $79B portfolio in Q4 2023.
- Lazard Asset Management opened 284 new positions and closed 260 in Q4 2023.
- Lazard Asset Management's portfolio value rose 7.5% quarter-over-quarter to $79B.
Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.